Biotransformation, estrogenicity, and steroid structure as determinants of dysmorphogenic and generalized embryotoxic effects of steroidal and nonsteroidal estrogens
- 1 March 1989
- journal article
- research article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 98 (1) , 113-127
- https://doi.org/10.1016/0041-008x(89)90139-7
Abstract
No abstract availableThis publication has 48 references indexed in Scilit:
- Contrasting effects of estradiol-17β and 17α-ethinyl estradiol-17β on cultured whole embryosJournal of Steroid Biochemistry, 1988
- Lesions of testis and epididymis associated with prenatal diethylstilbestrol exposure.Environmental Health Perspectives, 1988
- Tamoxifen Inhibits Estrogen-Induced Hepatic Injury in HamstersEndocrinology, 1988
- Conversion of estradiol-17β to reactive embryotoxic intermediates by cytochrome P-450-dependent bioactivating systemsBiochemical and Biophysical Research Communications, 1987
- Metabolism and irreversible binding of diethylstilbestrol in the kidney of the Syrian golden hamsterBiochemical Pharmacology, 1986
- Vitamin E prevents the platelet abnormalities induced by estrogen in ratContraception, 1984
- Mechanisms of TeratogenesisAnnual Review of Pharmacology and Toxicology, 1984
- Diethylstilbestrol-Induced Jaundice in the Chinese and Armenian HamsterHepatology, 1983
- Validation and characterization of the L5178Y/TK+/- mouse lymphoma mutagen assay systemMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1979
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976